Dasatinib and PD-L1 inhibitors provoke toxicity and inhibit angiogenesis in the embryo

Dasatinib and PD-L1 inhibitors provoke toxicity and inhibit angiogenesis in the embryo

<p dir="ltr">Dasatinib is a targeted cancer therapy, while programmed death ligand 1 (PD-L1) inhibitors are a form of immune checkpoint therapy used to treat various types of cancers. Several studies showed the potential efficacy of these drugs in the management of triple-negative br...

Full description

Saved in:
Bibliographic Details
Main Author: Maha Al-Asmakh (614593) (author)
Other Authors: Hiba Bawadi (3436379) (author), Munia Hamdan (17052372) (author), Ishita Gupta (9203073) (author), Hadeel Kheraldine (14231609) (author), Ayesha Jabeen (5438063) (author), Balsam Rizeq (14779402) (author), Ala-Eddin Al Moustafa (14153205) (author)
Published: 2021
Subjects:
Biomedical and clinical sciences
Pharmacology and pharmaceutical sciences
Dasatinib
PD-L/PD-L1
Embryo
Angiogenesis
Chorioallantoic membrane
Toxicity
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items